In conclusion, serum concentration changes of relatively non-specific host biomarkers, particularly IP-10, in response to the first week of anti-TB therapy were strongly associated with subsequent bacteriological confirmation of TB and provided early evidence of treatment response. This evidence concerns the gene CXCL10 and tuberculosis.